Simplex Trading, LLC Fibrogen Inc Transaction History

Simplex Trading, LLC

$2.98 Billion
Q2 2024

A detailed history of Simplex Trading, LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 77,253 shares of FGEN stock, worth $31,673. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,253

Previous 182,683 57.71%

Holding current value

$31,673

Previous $429,000 84.15%

% of portfolio

0.0%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$0.89 - $2.36 $93,832 - $248,814	-105,430 Reduced 57.71%	77,253 $68,000
Q1 2024 Apr 25, 2024	BUY	$0.73 - $2.73 $115,415 - $431,621	158,103 Added 643.22%	182,683 $429,000
Q4 2023 Feb 02, 2024	BUY	$0.38 - $0.91 $6,557 - $15,703	17,257 Added 235.65%	24,580 $21,000
Q3 2023 Nov 01, 2023	BUY	$0.79 - $2.83 $5,785 - $20,724	7,323 New	7,323 $6,000
Q1 2023 Apr 27, 2023	BUY	$15.95 - $25.18 $511,197 - $807,019	32,050 Added 5764.39%	32,606 $608,000
Q4 2022 Feb 02, 2023	SELL	$13.27 - $17.73 $112,250 - $149,978	-8,459 Reduced 93.83%	556 $8,000
Q3 2022 Nov 04, 2022	BUY	$11.4 - $14.6 $55,324 - $70,853	4,853 Added 116.6%	9,015 $117,000
Q2 2022 Aug 03, 2022	BUY	$7.94 - $12.96 $15,046 - $24,559	1,895 Added 83.59%	4,162 $43,000
Q1 2022 May 02, 2022	SELL	$12.02 - $16.79 $371,117 - $518,391	-30,875 Reduced 93.16%	2,267 $27,000
Q4 2021 Feb 23, 2022	SELL	$9.93 - $15.39 $559,972 - $867,872	-56,392 Reduced 62.98%	33,142 $467,000
Q3 2021 Oct 28, 2021	SELL	$10.18 - $26.64 $37,951 - $99,313	-3,728 Reduced 4.0%	89,534 $2.37 Million
Q2 2021 Aug 12, 2021	BUY	$18.57 - $35.68 $1.73 Million - $3.33 Million	93,262 New	93,262 $2.48 Million
Q1 2021 Apr 26, 2021	SELL	$31.0 - $55.72 $170,221 - $305,958	-5,491 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$37.09 - $48.97 $192,534 - $254,203	5,191 Added 1730.33%	5,491 $203,000
Q3 2020 Oct 14, 2020	SELL	$40.47 - $45.5 $426,756 - $479,797	-10,545 Reduced 97.23%	300 $12,000
Q2 2020 Jul 13, 2020	SELL	$32.57 - $42.83 $752,367 - $989,373	-23,100 Reduced 68.05%	10,845 $439,000
Q1 2020 Apr 29, 2020	SELL	$23.3 - $45.96 $442,327 - $872,504	-18,984 Reduced 35.87%	33,945 $1.18 Million
Q4 2019 Feb 05, 2020	BUY	$34.58 - $48.06 $1.57 Million - $2.19 Million	45,530 Added 615.35%	52,929 $2.27 Million
Q3 2019 Oct 15, 2019	SELL	$36.98 - $48.45 $435,402 - $570,450	-11,774 Reduced 61.41%	7,399 $273,000
Q2 2019 Jul 26, 2019	BUY	$35.13 - $55.53 $673,547 - $1.06 Million	19,173 New	19,173 $866,000
Q4 2018 Jan 16, 2019	SELL	$37.97 - $60.16 $458,297 - $726,131	-12,070 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$56.3 - $67.25 $499,662 - $596,843	-8,875 Reduced 42.37%	12,070 $733,000
Q2 2018 Jul 30, 2018	SELL	$44.9 - $64.95 $254,942 - $368,786	-5,678 Reduced 21.33%	20,945 $1.31 Million
Q1 2018 Apr 26, 2018	BUY	$45.35 - $61.65 $656,350 - $892,260	14,473 Added 119.12%	26,623 $1.23 Million
Q4 2017 Jan 10, 2018	SELL	$41.95 - $60.1 $1.38 Million - $1.98 Million	-32,921 Reduced 73.04%	12,150 $575,000
Q3 2017 Oct 25, 2017	BUY	$33.4 - $53.9 $1.51 Million - $2.43 Million	45,071	45,071 $2.42 Million

Others Institutions Holding FGEN

# of Institutions

115

Shares Held

57.5M

Call Options Held

2.14M

Put Options Held

907K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $38.4M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Fibrogen Inc Transaction History